A company still losing money with shrinking sales.
Facts from SEC filings, not a recommendation.
From BSEM's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
Move the sliders to your own view of BSEM. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
What today's price needs: with a 10% margin and a 15x P/E, sales could shrink about 17% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
Price chart by TradingView.
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: profitable every year, share count not growing. A checklist is a starting point for research, not a verdict.
No open-market insider buys or sells in the last 90 days.
No trades to chart yet.
SEC filings of any kind. 50 means a normal week.
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
250,000 shares at $2.00 · $500K
250,000 shares at $2.00 · $500K
4,234 shares
1,694 shares
Source: SEC EDGAR filings. For informational purposes. Not investment advice.
Report a problem with this page